BOCA RATON, Fla., Oct. 5 /PRNewswire/ -- NovaVision, Inc. today named John F. Sasen, Sr. to its board of directors. As a member of NovaVision's board of directors, Mr. Sasen will provide guidance on the continued development of NovaVision VRT(TM) Vision Restoration Therapy(TM)(VRT), the first FDA-cleared, non-invasive medical device to restore vision loss caused by stroke or traumatic brain injury (TBI).
"John F. Sasen, Sr. is an accomplished healthcare executive and will be a valuable asset to NovaVision," said NovaVision President and CEO Navroze Mehta. "Since receiving FDA clearance in 2003, NovaVision VRT has come a long way and is now available at more than 36 centers across the United States and around the world. We look forward to John's expertise and contributions as we continue to grow the business.
Mr. Sasen is executive vice president and chief marketing officer for PSS World Medical, Inc. in Jacksonville, Florida, a national distributor of medical supplies, equipment and pharmaceuticals to physicians and elder care providers. He has held senior management positions within the Company since he joined in 1990. Prior to joining PSS World Medical, he was with a division of Becton Dickinson, a manufacturer of healthcare products, for over 20 years. Mr. Sasen left Becton Dickinson as vice president, sales, marketing and distribution where he directed product development and marketing efforts, technical services, product services and customer service.
"NovaVision has successfully developed and commercialized a novel therapy that addresses a critical need for thousands of stroke and brain injury survivors for whom there was previously no solution," Mr. Sasen said. "I am pleased to join a company that is helping individuals improve their vision and quality of life."
In addition to his position at PSS World Medical and role on the NovaVision board of directors, Mr. Sasen is also a director of HESKA (HSKA), a manufacturer of companion animal products serving the veterinarian in practice, is Chairman of the Health Industry Distributors Association ("HIDA") Educational Foundation and is a member of the executive board of HIDA, a non-profit organization that addresses the needs of the healthcare industry.
About NovaVision, Inc.
NovaVision VRT(TM) Vision Restoration Therapy(TM) (VRT) is based on groundbreaking research in neuroplasticity. VRT is an FDA-cleared, patented, non-invasive medical device that may restore vision in stroke and traumatic brain injury (TBI) patients with visual deficits. While speech, physical and occupational therapy are the long-standing, mainstream treatment regimens for stroke and TBI patients, VRT is the first FDA-cleared clinical application of rehabilitation for vision loss. NovaVision, Inc. develops and distributes VRT.
NovaVision, Inc. is headquartered in Boca Raton, Florida with European offices that include clinics and research and development in Magdeburg, Germany. VRT is based on 15 years of research with clinical studies published in leading journals including Nature Medicine, Neurology, and The Journal of Cognitive Neuroscience. Data from a recent retrospective study identified that 70 percent of patients who underwent VRT for an initial six-month treatment period showed clinically meaningful improvements in their vision. VRT is currently offered at 30 leading medical institutions and private practices nationwide including the Neurological Institute of New York at Columbia University Medical Center, Department of Neurology at University of Miami, Emory Healthcare Eye Center, Rusk Institute of Rehabilitation Medicine at NYU Medical Center, Johns Hopkins University Wilmer Eye Institute, HealthSouth Sunrise Rehabilitation Hospital, HealthSouth Scottsdale Rehabilitation Hospital, HealthSouth Center for Neurological Research and Recovery in Houston, Doheny Eye Institute at USC, and others. For more information and a complete list of NovaVision VRT clinics please visit www.novavision.com or call 888.205.0800.
NovaVision, Inc.CONTACT: Rob Doll of NovaVision, Inc., +1-561-558-2003, orrdoll@novavision.com
Web site: http://www.novavision.com//
